Efficacy of Cortone injection on frozen shoulder

Phase 3

Recruiting

Conditions: frozen shoulder (adhesive capsulitis).
Adhesive capsulitis of shoulder
M75.0

Registration Number: IRCT20180423039388N1

Lead Sponsor: deputy of research - Iran university of medical science

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Recruiting

Sex: All

Target Recruitment: 72

Inclusion Criteria

patients with ages between 18 and 80
active and passive restriction of shoulder range of motion (forward flexion less than 100 degrees, external rotation less than 30 degrees, internal rotation less than L1 vertebra,
Stage 2 or 3 adhesive capsulitis according to the classification of Hannafin and Chiaia
complaint of pain for 1month at least and of ROM restriction for 3 months at least
written consent of participation in study

Exclusion Criteria

shoulder corticosteroids injection in last 6 months
chronic long-term use of oral corticosteroids or in last 2 weeks
history of shoulder surgery, shoulder fracture, shoulder dislocation in last 3 months
shoulder septic or inflammatory arthritis or any evidence in favor of shoulder cellulitis
uncontrolled Diabetes (HbA1C more than 7%, injection day BS more than 300)
cuff full thickness tear or cuff partial thickness tear more than 50% in shoulder MRI
Calcium deposition or Glenohumeral Osteoarthritis in shoulder AP and Axillary Xray
neuromuscular diseases, systemic skeletal diseases, skeletal or soft tissue cancers of shoulder or organs around the shoulder
use of Warfarin, Rivaroxaban, Apixaban, or any evidence in favor of bleeding susceptibility (INR>2, aptt>80 sec, platelet< 50000)

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pain. Timepoint: before injection and 1, 3 , 6 months after injection. Method of measurement: visual analog scale.;Shoulder range of motion. Timepoint: before injection and 1, 3 , 6 months after injection. Method of measurement: exam with goniometer.;Shoulder and pain disability. Timepoint: before injection and 6 months after injection. Method of measurement: SPADI questionnaire(Shoulder Pain And Disability Index).

Secondary Outcome Measures